重编程
骨化三醇受体
间质细胞
生物
癌症研究
胰腺癌
胰腺炎
受体
内科学
内分泌学
癌症
维生素D与神经学
细胞
生物化学
医学
遗传学
作者
Mara H. Sherman,Ruth T. Yu,Dannielle D. Engle,Ning Ding,Annette R. Atkins,Hervé Tiriac,Eric Andrew Collisson,Frances Connor,Terry Van Dyke,С. В. Козлов,Philip Martin,Tiffany W. Tseng,David W. Dawson,Timothy R. Donahue,Atsushi Masamune,Tooru Shimosegawa,Minoti Vivek Apte,Jeremy S. Wilson,Beverly Cheok Kuan Ng,Sue Lynn Lau
出处
期刊:Cell
[Cell Press]
日期:2014-09-01
卷期号:159 (1): 80-93
被引量:1238
标识
DOI:10.1016/j.cell.2014.08.007
摘要
The poor clinical outcome in pancreatic ductal adenocarcinoma (PDA) is attributed to intrinsic chemoresistance and a growth-permissive tumor microenvironment. Conversion of quiescent to activated pancreatic stellate cells (PSCs) drives the severe stromal reaction that characterizes PDA. Here, we reveal that the vitamin D receptor (VDR) is expressed in stroma from human pancreatic tumors and that treatment with the VDR ligand calcipotriol markedly reduced markers of inflammation and fibrosis in pancreatitis and human tumor stroma. We show that VDR acts as a master transcriptional regulator of PSCs to reprise the quiescent state, resulting in induced stromal remodeling, increased intratumoral gemcitabine, reduced tumor volume, and a 57% increase in survival compared to chemotherapy alone. This work describes a molecular strategy through which transcriptional reprogramming of tumor stroma enables chemotherapeutic response and suggests vitamin D priming as an adjunct in PDA therapy. PAPERFLICK:
科研通智能强力驱动
Strongly Powered by AbleSci AI